# Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following

> **NCT00606710** · — · COMPLETED · sponsor: **Guidant Corporation** · enrollment: 450 (estimated)

## Conditions studied

- Ventricular Tachycardia, Ventricular Fibrillation
- Heart Failure

## Interventions

- **DEVICE:** Cognis 100-D, Teligen DR, VR 100 HE

## Key facts

- **NCT ID:** NCT00606710
- **Lead sponsor:** Guidant Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2008-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00606710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00606710, "Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00606710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*